Interview with Tatiana Semiglazova
Interview with Tatiana Semiglazova, MD, DSci, Professor, Head of Department of Innovative Methods of Therapeutic Oncology and Rehabilitation, N.N. Petrov National Medical Research Center of Oncology (St. Petersburg, Russia), Professor at the Department of Oncology, I.I. Mechnikov North-Western State Medical University (St. Petersburg, Russia)...The topic of the interview is the rehabilitation of cancer patients...
RAKFOND NOMINATED FOR THE “HEADLINER OF THE YEAR” PRIZE
RakFond will participate in the competition for the "Headliner of the Year" National Prize in the "Science and Education" category. Voting will be open between October 16 and December 15, 2019. Please support us!
New interview with Kristina Zakurdaeva about the prospects of cancer control on “Russia 24” TV channel
The interviewee is a hematologist and the Founder of RakFond Kristina Zakurdaeva, MD, PhD. The interview is in Russian, with no translation available...
HOW FRAGILE ARE THE CLINICAL TRIALS SUPPORTING APPROVAL OF NOVEL ANTICANCER MEDICINES
A new article, recently published in The Lancet Oncology, raises a question of the fragility of phase 3, randomized, controlled trials supporting anticancer drugs that were approved by the FDA...
Interview with Andrei Gudkov
Interview with Andrei Gudkov, Ph.D., D.Sci., Senior Vice President, Research Technology and Innovation, Chair, Cell Stress Biology, Roswell Park Comprehensive Cancer Center (Buffalo, USA), Member of RakFond's Scientific Advisory Board... Learn about the relationship between cancer and evolution, what the scientists may be proud of, and where the curiosity leads us...
PRESENTATION OF THE STUDY SUPPORTED BY RAKFOND AT 2019 ASCO ANNUAL MEETING
Final results of the randomized phase II trial of olanzapine versus aprepitant in patients receiving high-emetogenic chemotherapy were presented by its author Dr. Alexey Rumyantsev at the Annual Meeting of the American Society of Clinical Oncology (ASCO) during the Symptoms and Survivorship session on June 3, 2019, in Chicago, USA...
SUBMISSION OF APPLICATIONS FOR THE CLINICAL RESEARCH PROJECTS COMPETITION IS CLOSED
Ten full applications were received in response to the Request For Proposals for the RakFond's competition of clinical research projects in oncology...
WHAT IS CLINICAL RESEARCH
RakFond's SAB Member Professor Nikolay Zhukov, MD, DSci, explains in this video what clinical research is, he describes different types of clinical studies, what they provide to medical doctors, and why taking part in clinical trials is important for patients...
NEWS OF THE 2019 ASCO ANNUAL MEETING: PART II
Compiled by Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting...
NEWS OF THE 2019 ASCO ANNUAL MEETING: PART I
The American Society of Clinical Oncology (ASCO) Annual Meeting took place at the beginning of June in Chicago, USA. Alexey Rumyantsev, MD in the Department of Clinical Pharmacology and Chemotherapy of the N.N. Blokhin National Medical Research Center of Oncology, RakFond’s grantee, IDEA (International Development and Education Award) awardee and this year’s presenter at the ASCO meeting, has put together the main news of the meeting...
